| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/NEN.0B013E3181E0D01C |
| P698 | PubMed publication ID | 20467328 |
| P50 | author | Bénédicte Chazaud | Q39061891 |
| Xavier Suárez-Calvet | Q41111982 | ||
| Eduard Gallardo | Q55718367 | ||
| Raúl Domínguez-Perles | Q57542906 | ||
| P2093 | author name string | Romain K Gherardi | |
| Corinne Sonnet | |||
| Isabel Illa | |||
| Noemí De Luna | |||
| P2860 | cites work | Macrophages and skeletal muscle regeneration: a clodronate-containing liposome depletion study | Q23918621 |
| Cell-type specific adhesive interactions of skeletal myoblasts with thrombospondin-1 | Q24305981 | ||
| Thrombospondin 1 promotes tumor macrophage recruitment and enhances tumor cell cytotoxicity of differentiated U937 cells | Q24308708 | ||
| AHNAK, a novel component of the dysferlin protein complex, redistributes to the cytoplasm with dysferlin during skeletal muscle regeneration | Q24337859 | ||
| Gene expression comparison of biopsies from Duchenne muscular dystrophy (DMD) and normal skeletal muscle | Q24538577 | ||
| Gene expression variation between mouse inbred strains | Q24806230 | ||
| Activation of latent TGF-beta by thrombospondin-1: mechanisms and physiology | Q28138090 | ||
| Dysferlin is a plasma membrane protein and is expressed early in human development | Q28140994 | ||
| Defective membrane repair in dysferlin-deficient muscular dystrophy | Q28203095 | ||
| Dysferlin Interacts with Annexins A1 and A2 and Mediates Sarcolemmal Wound-healing | Q28204713 | ||
| Gene expression profiling in DQA1*0501+ children with untreated dermatomyositis: a novel model of pathogenesis | Q28213371 | ||
| A chronic inflammatory response dominates the skeletal muscle molecular signature in dystrophin-deficient mdx mice | Q28217143 | ||
| Membrane repair defects in muscular dystrophy are linked to altered interaction between MG53, caveolin-3, and dysferlin | Q28241932 | ||
| Cyclin D1 functions in cell migration | Q28274139 | ||
| Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy | Q28281738 | ||
| A gene related to Caenorhabditis elegans spermatogenesis factor fer-1 is mutated in limb-girdle muscular dystrophy type 2B | Q28281749 | ||
| Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis | Q29622851 | ||
| Making sense of the limb-girdle muscular dystrophies | Q33701932 | ||
| A web-accessible complete transcriptome of normal human and DMD muscle | Q34147123 | ||
| Macrophages promote muscle membrane repair and muscle fibre growth and regeneration during modified muscle loading in mice in vivo | Q34573648 | ||
| Cloning of cDNA encoding a regeneration-associated muscle protease whose expression is attenuated in cell lines derived from Duchenne muscular dystrophy patients. | Q35098086 | ||
| Human brain glial cells synthesize thrombospondin | Q35602576 | ||
| Up-regulation of MHC class I expression accompanies but is not required for spontaneous myopathy in dysferlin-deficient SJL/J mice | Q35788717 | ||
| The lack of thrombospondin-1 (TSP1) dictates the course of wound healing in double-TSP1/TSP2-null mice | Q35789152 | ||
| Macrophage recognition and phagocytosis of apoptotic fibroblasts is critically dependent on fibroblast-derived thrombospondin 1 and CD36. | Q35791278 | ||
| Thrombospondin: synthesis and secretion by cells in culture | Q36206956 | ||
| Synthesis and secretion of thrombospondin by cultured human endothelial cells | Q36208911 | ||
| Unique distribution of the extracellular matrix component thrombospondin in the developing mouse embryo | Q36220977 | ||
| Satellite cells attract monocytes and use macrophages as a support to escape apoptosis and enhance muscle growth. | Q36324730 | ||
| Expression profiling in the muscular dystrophies: identification of novel aspects of molecular pathophysiology | Q36360412 | ||
| Dysferlin deficiency enhances monocyte phagocytosis: a model for the inflammatory onset of limb-girdle muscular dystrophy 2B. | Q36482213 | ||
| The role of the thrombospondins in healing myocardial infarcts | Q36723963 | ||
| Dysferlin in membrane trafficking and patch repair. | Q36839858 | ||
| Dysferlin deficiency shows compensatory induction of Rab27A/Slp2a that may contribute to inflammatory onset. | Q36943096 | ||
| Thrombospondins in cancer | Q37056249 | ||
| Applications of metabolomics and proteomics to the mdx mouse model of Duchenne muscular dystrophy: lessons from downstream of the transcriptome | Q37149236 | ||
| Cultured human fibroblasts synthesize and secrete thrombospondin and incorporate it into extracellular matrix | Q37603919 | ||
| Selection of multipotent cells and enhanced muscle reconstruction by myogenic macrophage-secreted factors | Q39860215 | ||
| Opposite effects of thrombospondin-1 via CD36 and CD47 on homotypic aggregation of monocytic cells | Q40704738 | ||
| Macrophages enhance muscle satellite cell proliferation and delay their differentiation | Q40809908 | ||
| Blood borne macrophages are essential for the triggering of muscle regeneration following muscle transplant | Q40815680 | ||
| The earliest pathologic alterations in dysferlinopathy | Q42505709 | ||
| Inflammation in dysferlin myopathy: immunohistochemical characterization of 13 patients. | Q43820156 | ||
| Identification of integrin alpha 3 beta 1 as a neuronal thrombospondin receptor mediating neurite outgrowth | Q46148499 | ||
| Regenerated mdx mouse skeletal muscle shows differential mRNA expression | Q46302846 | ||
| Urokinase-type plasminogen activator plays essential roles in macrophage chemotaxis and skeletal muscle regeneration | Q46820186 | ||
| Temporal gene expression profiling of dystrophin-deficient (mdx) mouse diaphragm identifies conserved and muscle group-specific mechanisms in the pathogenesis of muscular dystrophy | Q47314000 | ||
| The COX-2 pathway is essential during early stages of skeletal muscle regeneration | Q47764574 | ||
| Gene expression profiling of Duchenne muscular dystrophy skeletal muscle | Q47970351 | ||
| Disruption of muscle membrane and phenotype divergence in two novel mouse models of dysferlin deficiency. | Q50489087 | ||
| Absence of dysferlin alters myogenin expression and delays human muscle differentiation "in vitro". | Q52021000 | ||
| Upregulation of thrombospondin-1(TSP-1) and its binding partners, CD36 and CD47, in sporadic inclusion body myositis. | Q53546253 | ||
| Microarray analysis of mdx mice expressing high levels of utrophin: therapeutic implications for dystrophin deficiency. | Q53546445 | ||
| Dysferlin deletion in SJL mice (SJL-Dysf) defines a natural model for limb girdle muscular dystrophy 2B | Q57990899 | ||
| Dysferlin expression in monocytes: A source of mRNA for mutation analysis | Q58380569 | ||
| P433 | issue | 6 | |
| P921 | main subject | inflammation | Q101991 |
| macrophage | Q184204 | ||
| P304 | page(s) | 643-653 | |
| P577 | publication date | 2010-06-01 | |
| P1433 | published in | Journal of Neuropathology & Experimental Neurology | Q15716771 |
| P1476 | title | Role of thrombospondin 1 in macrophage inflammation in dysferlin myopathy | |
| P478 | volume | 69 |
| Q42233198 | Altered RIG-I/DDX58-mediated innate immunity in dermatomyositis. |
| Q51089580 | Annexin A2 links poor myofiber repair with inflammation and adipogenic replacement of the injured muscle. |
| Q35632288 | CD4+ cells, macrophages, MHC-I and C5b-9 involve the pathogenesis of dysferlinopathy |
| Q33732669 | Dendritic cell-derived thrombospondin-1 is critical for the generation of the ocular surface Th17 response to desiccating stress. |
| Q40776035 | Dysferlin regulates cell adhesion in human monocytes. |
| Q38092854 | Dysferlin-deficient muscular dystrophy and innate immune activation. |
| Q41447617 | Hypoxia triggers IFN-I production in muscle: Implications in dermatomyositis. |
| Q91446266 | Immunobiology of Inherited Muscular Dystrophies |
| Q90267744 | Long-range genomic regulators of THBS1 and LTBP4 modify disease severity in duchenne muscular dystrophy |
| Q46011476 | Methotrexate combined with methylprednisolone for the recovery of motor function and differential gene expression in rats with spinal cord injury. |
| Q42209023 | Muscle membrane repair and inflammatory attack in dysferlinopathy. |
| Q34103354 | Myogenesis in dysferlin-deficient myoblasts is inhibited by an intrinsic inflammatory response |
| Q60301434 | Patients with anti-Jo1 antibodies display a characteristic IgG Fc-glycan profile which is further enhanced in anti-Jo1 autoantibodies |
| Q33747737 | Proteomic analysis of the dysferlin protein complex unveils its importance for sarcolemmal maintenance and integrity |
| Q50066457 | Thrombospondin-1 and disease progression in dysferlinopathy. |
| Q90117305 | Thrombospondin-1 mediates muscle damage in brachio-cervical inflammatory myopathy and systemic sclerosis |
| Q35098885 | Thrombospondin-1: multiple paths to inflammation |
| Q37873747 | Translational research and therapeutic perspectives in dysferlinopathies. |
Search more.